The philanthropic organization FJC recently awarded a $1 million grant to the Institute for Myeloma and Bone Cancer Research (IMBCR).

The grant will go toward IMBCR’s “Cure Myeloma Project,” a research project IMBCR claims is the nation’s foremost effort to find a cure for multiple myeloma.

Specifically, the money will fund six research projects to be conducted by leading myeloma scientists. The topics of these projects are:

• Tumor necrosis factor receptor 6 (TRAF6) dominant negative peptides - According to IMBCR, blocking TRAF6 expression may hinder cell growth and

 …